Since pregnant women with COVID-19 have higher odds of preterm birth [76], future studies are required to assess whether ACE2 expressing maternal peripheral immune cells infected by SARS-CoV-2 can traffic to the placenta and be involved with increased risk of preterm birth and or placental COVID infection in pregnant women with Covid-19. This evidence concerns the gene ACE2 and COVID-19.